Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. 4 Insider Changes in Ownership
  4. 10-K Report Annual Report
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 424B4 Offering Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. S-1MEF Other S-1MEF
  11. S-1/A Offering Registration Statement
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. FWP Offering Free Writing Prospectus
  17. FWP Offering Free Writing Prospectus
  18. 8-K Event Results of operations
  19. S-1/A Offering Registration Statement
  20. S-1 Offering Registration Statement

Page 38 of 41 · 819 filings